Chemed (NYSE:CHE – Get Free Report) is expected to post its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Chemed to post earnings of $7.02 per share and revenue of $659.0860 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 26, 2026 at 10:00 AM ET.
Chemed Stock Up 0.7%
NYSE:CHE opened at $475.35 on Monday. Chemed has a twelve month low of $408.42 and a twelve month high of $623.60. The company has a fifty day moving average of $444.77 and a 200-day moving average of $443.67. The firm has a market capitalization of $6.73 billion, a P/E ratio of 25.14, a P/E/G ratio of 2.32 and a beta of 0.44.
Chemed Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Monday, February 23rd. Chemed’s payout ratio is 12.69%.
Institutional Trading of Chemed
Wall Street Analyst Weigh In
CHE has been the topic of a number of research analyst reports. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada cut their price target on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Chemed presently has a consensus rating of “Moderate Buy” and an average target price of $555.50.
Check Out Our Latest Analysis on Chemed
Chemed Company Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Read More
- Five stocks we like better than Chemed
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
